{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:46:03Z","timestamp":1782906363536,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,12,20]],"date-time":"2010-12-20T00:00:00Z","timestamp":1292803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,12,20]],"date-time":"2010-12-20T00:00:00Z","timestamp":1292803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1038\/bmt.2010.314","type":"journal-article","created":{"date-parts":[[2010,12,20]],"date-time":"2010-12-20T12:32:51Z","timestamp":1292848371000},"page":"1413-1417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["BU- vs TBI-based conditioning for adult patients with ALL"],"prefix":"10.1038","volume":"46","author":[{"given":"M","family":"Kalaycio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Bolwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Rybicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Absi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Andresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Pohlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Sobecks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Copelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,20]]},"reference":[{"key":"BFbmt2010314_CR1","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"AH Goldstone","year":"2008","unstructured":"Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck J, Fielding AK et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation\/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII\/ECOG E2993). Blood 2008; 111: 1827\u20131833.","journal-title":"Blood"},{"key":"BFbmt2010314_CR2","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1046\/j.1365-2141.1996.d01-1681.x","volume":"93","author":"O Ringden","year":"1996","unstructured":"Ringden O, Labopin M, Tura S, Arcese W, Iriondo A, Zittoun R et al. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 1996; 93: 637\u2013645.","journal-title":"Br J Haematol"},{"key":"BFbmt2010314_CR3","first-page":"1060","volume":"85","author":"E Granados","year":"2000","unstructured":"Granados E, de La Camara R, Madero L, Diaz MA, Martin-Regueira P, Steegmann JL et al. Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation. Haematologica 2000; 85: 1060\u20131067.","journal-title":"Haematologica"},{"key":"BFbmt2010314_CR4","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1200\/JCO.2004.07.130","volume":"22","author":"MG Kiehl","year":"2004","unstructured":"Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N et al. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. J Clin Oncol 2004; 22: 2816\u20132825.","journal-title":"J Clin Oncol"},{"key":"BFbmt2010314_CR5","first-page":"33","volume":"20","author":"EA Copelan","year":"1993","unstructured":"Copelan EA, Biggs JC, Szer J, Thompson JM, Crilley P, Brodsky I et al. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2). Semin Oncol 1993; 20: 33\u201338.","journal-title":"Semin Oncol"},{"key":"BFbmt2010314_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1200\/JCO.1992.10.2.237","volume":"10","author":"EA Copelan","year":"1992","unstructured":"Copelan EA, Biggs JC, Avalos BR, Szer J, Cunningham I, Klein JP et al. Radiation-free preparation for allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia. J Clin Oncol 1992; 10: 237\u2013242.","journal-title":"J Clin Oncol"},{"key":"BFbmt2010314_CR7","first-page":"907","volume":"18","author":"EA Copelan","year":"1996","unstructured":"Copelan EA, Penza SL, Elder PJ, Belt PS, Scholl MD, Hehmeyer DM et al. Influence of graft-versus-host disease on outcome following allogeneic transplantation with radiation-free preparative therapy in patients with advanced leukemia. Bone Marrow Transplant 1996; 18: 907\u2013911.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010314_CR8","first-page":"3983","volume":"93","author":"M Wetzler","year":"1999","unstructured":"Wetzler M, Dodge RK, Mrozek K, Carroll AJ, Tantravahi R, Block AW et al. Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. Blood 1999; 93: 3983\u20133993.","journal-title":"Blood"},{"key":"BFbmt2010314_CR9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.bbmt.2008.04.003","volume":"14","author":"D Weisdorf","year":"2008","unstructured":"Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 2008; 14: 748\u2013758.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2010314_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.bmt.1704736","volume":"35","author":"M Kalaycio","year":"2005","unstructured":"Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Ball E, Cook D et al. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens. Bone Marrow Transplant 2005; 35: 247\u2013252.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010314_CR11","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.exphem.2003.09.008","volume":"31","author":"C Ferry","year":"2003","unstructured":"Ferry C, Socie G . Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned? Exp Hematol 2003; 31: 1182\u20131186.","journal-title":"Exp Hematol"},{"key":"BFbmt2010314_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/sj.bmt.1705595","volume":"39","author":"DI Marks","year":"2007","unstructured":"Marks DI . Conditioning regimens for acute lymphoblastic leukaemia allografts. Bone Marrow Transplant 2007; 39: 377; author reply 378.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010314_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/sj.bmt.1704198","volume":"32","author":"N Bunin","year":"2003","unstructured":"Bunin N, Aplenc R, Kamani N, Shaw K, Cnaan A, Simms S . Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study. Bone Marrow Transplant 2003; 32: 543\u2013548.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010314_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/sj.bmt.1704605","volume":"34","author":"QY Dai","year":"2004","unstructured":"Dai QY, Souillet G, Bertrand Y, Galambrun C, Bleyzac N, Manel AM et al. Antileukemic and long-term effects of two regimens with or without TBI in allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia. Bone Marrow Transplant 2004; 34: 667\u2013673.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010314_CR15","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V93.7.2196","volume":"93","author":"O Ringden","year":"1999","unstructured":"Ringden O, Remberger M, Ruutu T, Nikoskelainen J, Volin L, Vindel\u00f8v L et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group. Blood 1999; 93: 2196\u20132201.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2010314.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2010314","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2010314.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T13:13:25Z","timestamp":1648041205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2010314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,20]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["BFbmt2010314"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2010.314","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,20]]},"assertion":[{"value":"12 May 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Sobecks receives research support from Otsuka America Pharmaceutical Inc. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}